Markets:

Overview

News

Currencies

International

Treasuries

Annovis Bio, Inc. Common Stock (NY:ANVS)

4.820 +0.730 (+17.85%)

Official Closing Price Updated: 7:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Annovis Bio, Inc. Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Lawsuits Filed Against LIVE, ANVS and ATIP - Jakubowitz Law Pursues Shareholders Claims

August 20, 2021

NEW YORK, NY / ACCESSWIRE / August 20, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies...

From Jakubowitz Law

Via AccessWire

Topics Fraud Lawsuit

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of DIDI, ATVI and ANVS

August 20, 2021

NEW YORK, NY / ACCESSWIRE / August 20, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

From The Gross Law Firm

Via AccessWire

Topics Initial Public Offering Lawsuit

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of BZ, CXO and ANVS

August 19, 2021

NEW YORK, NY / ACCESSWIRE / August 19, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

From The Gross Law Firm

Via AccessWire

ANNOVIS BIO SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Annovis Bio, Inc. - ANVS

August 19, 2021

From Kahn Swick & Foti, LLC

Via Business Wire

SHAREHOLDER ALERT: PHG ANVS ATIP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

August 19, 2021

NEW YORK, NY / ACCESSWIRE / August 19, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a...

From The Law Offices of Vincent Wong

Via AccessWire

Topics Fraud Lawsuit

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRAC, ATHA and ANVS

August 19, 2021

NEW YORK, NY / ACCESSWIRE / August 19, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to...

From The Klein Law Firm

Via AccessWire

Topics Fraud Intellectual Property Lawsuit

CLASS ACTION UPDATE for RKT, BZ and ANVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

August 19, 2021

NEW YORK, NY / ACCESSWIRE / August 19, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies....

From Levi & Korsinsky, LLP

Via AccessWire

Topics Lawsuit

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Annovis Bio, Inc. (ANVS)

August 19, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

ANNOVIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Annovis Bio, Inc. and Encourages Investors to Contact the Firm

August 18, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

ANVS ALERT: Investors With Substantial Losses Have Opportunity to Lead the Annovis Bio, Inc. Class Action Lawsuit

August 18, 2021

From Robbins Geller Rudman & Dowd LLP

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

August 18, 2021

From The Schall Law Firm

Via Business Wire

EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Annovis Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline – ANVS

August 18, 2021

From The Rosen Law Firm, P.A.

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Annovis Bio, Inc. (ANVS) Investors

August 18, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Annovis Bio, Inc. (ANVS) Investors

August 18, 2021

From Law Offices of Howard G. Smith

Via Business Wire

ANVS CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Annovis Bio, Inc.

August 17, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

Why Is Biogen Pursuing a New Direction in Alzheimer's Research? ↗

August 13, 2021

It might be that Biogen, too, is abandoning the theory that amyloid plaque is the cause of the disease.

Via The Motley Fool

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors

August 05, 2021

From Law Offices of Howard G. Smith

Via Business Wire

ANNOVIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Annovis Bio, Inc. on Behalf of Annovis Stockholders and Encourages Investors to Contact the Firm

August 03, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors

August 03, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

99 Biggest Movers From Yesterday ↗

August 06, 2021

Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...

Via Benzinga

The Law Offices of Frank R. Cruz Announces Investigation of Annovis Bio, Inc. (ANVS) on Behalf of Investors

August 03, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

61 Biggest Movers From Yesterday ↗

August 03, 2021

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares climbed 124.8% to close at $5.08 on Monday after the company announced a $5 million stock repurchase program....

Via Benzinga

INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Annovis Bio, Inc.

August 02, 2021

From Kirby McInerney LLP

Via Business Wire

40 Stocks Moving In Monday's Mid-Day Session ↗

August 02, 2021

Gainers Ever-Glory International Group, Inc. (NASDAQ: EVK) shares jumped 133% to $5.27 after the company announced a $5 million stock repurchase program. Exicure, Inc. (NASDAQ:...

Via Benzinga

Here's Why Annovis Bio, Anavex Life Sciences, and Cassava Sciences Sank on Thursday ↗

July 29, 2021

A clinical-trial flop for Annovis Bio is reminding investors that developing new drugs for Alzheimer's disease is an extremely risky business.

Via The Motley Fool

63 Biggest Movers From Friday ↗

August 02, 2021

Gainers ERYTECH Pharma S.A. (NASDAQ: ERYP) shares surged 55% to close at $6.37 on Friday after the company said the FDA has granted its eryaspase fast track designation for the...

Via Benzinga

ANVS Stock: The Alzheimer’s Drug News That Has Annovis Bio Plunging Today ↗

July 29, 2021

Shares of ANVS stock are plummeting on Thursday after Annovis Bio reported weak results from two clinical trials for its leading drug.

Via InvestorPlace

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

70 Biggest Movers From Yesterday ↗

July 30, 2021

Gainers Xenetic Biosciences, Inc. (NASDAQ: XBIO) shares surged 65.1% to settle at $5.30 on Thursday. Xenetic Biosciences recently reported closing of $12.5 million private...

Via Benzinga

Annovis Bio Shares Cut In Half Following Alzheimer's Data Presentation ↗

July 29, 2021

Annovis Bio, Inc. (NYSE: ANVS), which took off on a strong rally in January, has quickly lost most of the gains. What To Know: Annovis, a clinical-stage neurodegenerative diseases...

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Annovis Bio, Inc. Common Stock (NY:ANVS)

All News about Annovis Bio, Inc. Common Stock

Starting at $3.75/week.

Subscribe Today